Skip to main content

Economics of low-molecular weight heparins.

Publication ,  Journal Article
Rutschmann, OT; Matchar, DB
Published in: Am J Manag Care
November 2000

Low-molecular weight heparins (LMWHs) have become attractive alternatives to standard unfractionated heparin (UFH) for the treatment and prophylaxis of deep vein thrombosis (DVT), and for the management of acute coronary syndrome (ACS). The economic impact of the use of LMWHs has been studied in randomized controlled studies, in demonstration projects in managed care institutions, and in decision models. These studies provide valuable insight into the ways LMWHs can be economically attractive despite higher per unit costs compared with UFH. For the treatment of DVT, the cost benefit of using LMWHs results primarily from the cost shifting from inpatient to outpatient care, and might be limited by the eligibility of patients for outpatient management. In contrast, the attractiveness of LMWHs for ACS and DVT prophylaxis hinges on the increased effectiveness of LMWHs compared with standard UFH.

Duke Scholars

Published In

Am J Manag Care

ISSN

1088-0224

Publication Date

November 2000

Volume

6

Issue

20 Suppl

Start / End Page

S1054 / S1065

Location

United States

Related Subject Headings

  • Venous Thrombosis
  • United States
  • Managed Care Programs
  • Humans
  • Hospital Costs
  • Heparin, Low-Molecular-Weight
  • Health Policy & Services
  • Education, Pharmacy, Continuing
  • Education, Medical, Continuing
  • Drug Costs
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rutschmann, O. T., & Matchar, D. B. (2000). Economics of low-molecular weight heparins. Am J Manag Care, 6(20 Suppl), S1054–S1065.
Rutschmann, O. T., and D. B. Matchar. “Economics of low-molecular weight heparins.Am J Manag Care 6, no. 20 Suppl (November 2000): S1054–65.
Rutschmann OT, Matchar DB. Economics of low-molecular weight heparins. Am J Manag Care. 2000 Nov;6(20 Suppl):S1054–65.
Rutschmann, O. T., and D. B. Matchar. “Economics of low-molecular weight heparins.Am J Manag Care, vol. 6, no. 20 Suppl, Nov. 2000, pp. S1054–65.
Rutschmann OT, Matchar DB. Economics of low-molecular weight heparins. Am J Manag Care. 2000 Nov;6(20 Suppl):S1054–S1065.

Published In

Am J Manag Care

ISSN

1088-0224

Publication Date

November 2000

Volume

6

Issue

20 Suppl

Start / End Page

S1054 / S1065

Location

United States

Related Subject Headings

  • Venous Thrombosis
  • United States
  • Managed Care Programs
  • Humans
  • Hospital Costs
  • Heparin, Low-Molecular-Weight
  • Health Policy & Services
  • Education, Pharmacy, Continuing
  • Education, Medical, Continuing
  • Drug Costs